Physician profile
Scott E Strohmeyer
NPI 1538195946
$1,649.00
in general payments reported to CMS, 2019-2025
13 companies · $544 in 2025
The $544 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $36.64 · 2021: $68.16 · 2022: $109 · 2023: $56.90 · 2024: $160 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561 · Travel and Lodging: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.07 |
| Travel and Lodging | $199.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $640.98 | 2019-2022 | |
| Depuy Synthes Sales INC. | $361.46 | 2020-2025 | Velys, Vivigen Mis Delivery System, Conduit |
| Medical Device Business Services, INC. | $285.40 | 2025 | Velys |
| Pacira Therapeutics, INC. | $156.59 | 2019-2021 | |
| Boston Scientific Corporation | $59.68 | 2024 | |
| Pfizer INC. | $27.99 | 2021 | |
| Curonix LLC | $20.44 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $19.02 | 2025 | Plasmablade(Tm) |
| Abbott Laboratories | $18.57 | 2023 | Proclaim |
| Sanara Medtech INC. | $18.36 | 2024 | Celleraterx |
| Innovation Technologies INC | $14.71 | 2025 | Irrisept |
| Medacta USA, INC. | $13.13 | 2019 | |
| Paradigm Spine, LLC | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Strohmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.